# A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia

> **NCT01779453** · PHASE2 · COMPLETED · sponsor: **Esperion Therapeutics, Inc.** · enrollment: 58 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** ETC-1002
- **DRUG:** Placebo
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT01779453
- **Lead sponsor:** Esperion Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2019-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01779453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01779453, "A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01779453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*